Genetic and Pharmacological Inhibition of Rheb1-mTORC1 Signaling Exerts Cardioprotection against Adverse Cardiac Remodeling in MiceXiangqi Wu, Xinli Li|American Journal Of Pathology|2013Cited by 73
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN studyShao‐Liang Chen, Xiangqi Wu, Jing Kan et al.|American Heart Journal|2024Cited by 5